336 related articles for article (PubMed ID: 4856883)
1. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
Crum ED; Shainoff JR; Graham RC; Ratnoff OD
J Clin Invest; 1974 May; 53(5):1308-19. PubMed ID: 4856883
[TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of an inherited abnormal fibrinogen: fibrinogen "Baltimore".
Beck EA; Shainoff JR; Vogel A; Jackson DP
J Clin Invest; 1971 Sep; 50(9):1874-84. PubMed ID: 5564395
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
[TBL] [Abstract][Full Text] [Related]
4. Dysfibrinogenemia associated with liver disease.
Palascak JE; Martinez J
J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen St. Louis: a new inherited fibrinogen variant, coincidentally associated with hemophilia A.
Sherman LA; Gaston LW; Kaplan ME; Spivack AR
J Clin Invest; 1972 Mar; 51(3):590-7. PubMed ID: 4622105
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
Gralnick HR; Givelber HM; Shainoff JR; Finlayson JS
J Clin Invest; 1971 Sep; 50(9):1819-30. PubMed ID: 5564389
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
[TBL] [Abstract][Full Text] [Related]
9. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
Lane DA; Cuddigan B; VanRoss M; Kakkar VV
Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
[TBL] [Abstract][Full Text] [Related]
10. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
[TBL] [Abstract][Full Text] [Related]
11. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
12. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
Matsuda M; Baba M; Morimoto K; Nakamikawa C
J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
[TBL] [Abstract][Full Text] [Related]
13. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
14. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
Brown CH; Crowe MF
J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
[TBL] [Abstract][Full Text] [Related]
15. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
[TBL] [Abstract][Full Text] [Related]
16. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
17. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
[TBL] [Abstract][Full Text] [Related]
19. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
Peyer A; Straub PW
Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
[No Abstract] [Full Text] [Related]
20. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
Furlan M; Stucki B; Steinmann C; Jungo M; Lämmle B
Thromb Haemost; 1996 Sep; 76(3):377-83. PubMed ID: 8883274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
